DOI: 10.1055/s-00022861

Aktuelle Kardiologie

LinksClose Window

References

FDA.
FDA Drug Safety Communication: Ongoing safety review of high-dose Zocor (simvastatin) and increased risk of muscle injury (19. März 2010):.

http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm204882.htm Stand: 2. Juni 2010

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.